Design and synthesis of novel isatin-based hybrids as dual PARP1/CDK2 inhibitors targeting BRCA wild-type TNBC

Journal of Molecular Structure 2026

View at publisher

Authors: Asmaa G. Safi El-Din, Nashwa A. Ibrahim, Mohamed R. Elnagar, Amr Farouk, Mai M. Abdelhameed, Eman G. Said

DOI: 10.1016/j.molstruc.2026.147094

Cited by: 1

References: 91

Fields of Study & Subjects

PARP inhibition in cancer therapy Advanced Breast Cancer Therapies Cancer-related Molecular Pathways

References 91